ACTIVE SUBSTANCE / INN

NALOXONE HYDROCHLORIDE

Brand name(s): NALOXONE, BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE, ZIMHI, NARCAN, NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA070188
ANDA091149
ACTIVE SUBSTANCE
Naloxone Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, ACTAVIS LABS UT INC, WYETH AYERST
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA207000SPECGX LLCPrescription
ZIMHINDA212854ZMI PHARMAPrescription
NALOXONEANDA070188WYETH AYERSTDiscontinued
NALOXONE HYDROCHLORIDEANDA070257HOSPIRAPrescription
NALOXONE HYDROCHLORIDEANDA070639INTL MEDICATIONDiscontinued
NALOXONEANDA070299HIKMAPrescription
NARCANANDA071311BRISTOL MYERS SQUIBBDiscontinued
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA074736WATSON LABSPrescription
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA091149TEVA PHARMS USADiscontinued
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEANDA204383ACTAVIS LABS UT INCNone (Tentative Approval)

FULL INTELLIGENCE ON NALOXONE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →